Fastin (60 tablets) A new quick acting thermogenic intensifier designed for resounding energy and fat loss for women and men who have difficulty losing weight!
Fastin Novel Stimulant Formulation!
Fastin formerly from King Pharmacuticals with Trade rights aquired by Hi-Tech Pharmaceuticals, is a new quick acting thermogenic intensifier designed for resounding energy and fat loss. Fastin contains a proprietary matrix of powerful stimulant actives. At the heart of this unique compound lie Phenylethylamine HCL and its molecular derivatives, including methylphenylethylamine and methylsynephrine.
Fastin was based on a drug called Phentermine is a stimulant that is similar to an amphetamine. Phentermine is an appetite suppressant that affects the central nervous system. Phentermine is used togther with diet and exercise to treat obesity (overweight) in people with risk factors such as high blood pressure, high cholesterol, or diabetes.The new active ingredient in Fastin is (ß-methyl-phenethylamine) 37.5mg which may overlap and should not be combined with other phenethylamines including phentermine, fenfluramine, amphetamine, cathinone and the synthetic drug dextroamphetamine and methylphenidate or other substituted phenethylamines.
Fastin is considered to be a Sympathomimetic appetite suppressant. Sympathomimetic appetite suppressants are used in the short-term treatment of obesity. Their appetite-reducing effect tends to decrease after a few weeks. The sympathomimetic appetite suppressants (Fastin) can help you to lose weight while you are learning new ways to eat and to exercise. Changes in eating habits and activity level must be developed to truly benefit from Fastin!
Fastin is a true 'Mood Promoter' whose stimulant effects are rapid, yet exceptionally even throughout each dose. Weight loss design includes increased lipolysis (fat loss) accompanied by elevated mood and high-energy levels in combination with a reduced caloric intake and increased metabolic expenditure typical of an effective overall weight loss plan.
No comments:
Post a Comment